Trademark: 88219381
Word
EVERFILL
Status
Registered
Status Code
700
Status Date
Tuesday, March 9, 2021
Serial Number
88219381
Registration Number
6285602
Registration Date
Tuesday, March 9, 2021
Mark Type
4000
Filing Date
Thursday, December 6, 2018
Published for Opposition
Tuesday, December 22, 2020

Trademark Owner History
Everfill Oy - Original Registrant

Classifications
5 Cell-free tissue preparations, namely, human and animal adipose tissue extracts for regeneration of skin and and subcutaneous tissue for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Biological tissue for implantation, namely, biological skin tissue intended for subsequent implantation; Skin grafts; Biological tissue cultures for medical purposes; Human allograft tissue; Pharmaceutical and medicinal preparations, namely, pharmaceutical and medicinal extracts in the nature of human and animal adipose tissue extracts for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Synergists and adjuvants for living tissues for medical purposes; Synergists and adjuvants for live organs and tissues for medical surgical purposes; Processed human donor skin for the replacement of soft tissue; Medicinal healthcare preparations in the nature of human and animal adipose tissue extract for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Pharmaceutical preparations for treating skin disorders; Skin care preparations for medical use; Pharmaceutical preparations for use in tissue transplantation, specifically, for regeneration of skin; Pharmaceutical preparations for the regeneration of tissue; Adhesive bandages for skin wounds; Medical dressings; Pharmaceuticals and natural remedies all in the nature of human and animal adipose tissue extracts for regeneration of tissue for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Preparations for cleansing the skin for medical use; Adhesive skin patches for medical use, namely, medicinal patches for the treatment of skin defects; Medicated skin care preparations
3 Non-medicated cosmetic preparations, namely, non-medicated cosmetic preparations formed from extracts derived from human and animal tissue sold as components of cosmetics; Non-medicated cosmetics
44 Human healthcare; Medical services; Dermatological services for treating skin conditions; Medical services for treatment of the skin; Medical services for the care of the skin; Medical diagnostic reporting, monitoring, advice, consultancy, and information relating to any of the aforesaid services
10 Medical equipment and accessory equipment, namely, medical devices for the treatment of skin defects, specifically, hydrogels; Artificial skin replacing membranes, namely, artificial skin for replacing blemished, scarred, disfigured or unhealthy skin in order to treat skin defects; Sutures; Wound closing materials and products, namely, medical devices for closing wounds; Artificial skin implants; Transplant sutures for use in surgery; none of the abovementioned products being related to extracorporeal blood treatment and renal insufficiency; Medical applicators, namely, injection syringes, injection needles and catheters

Trademark Events
Feb 18, 2022
Teas Change Of Correspondence Received
Feb 18, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 18, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 9, 2021
Registered-Principal Register
Dec 22, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 22, 2020
Published For Opposition
Dec 2, 2020
Notification Of Notice Of Publication E-Mailed
Nov 19, 2020
Approved For Pub - Principal Register
Nov 16, 2020
Teas/Email Correspondence Entered
Nov 16, 2020
Correspondence Received In Law Office
Nov 16, 2020
Teas Response To Office Action Received
Nov 13, 2020
Notification Of Non-Final Action E-Mailed
Nov 13, 2020
Non-Final Action E-Mailed
Nov 13, 2020
Non-Final Action Written
Oct 15, 2020
Teas/Email Correspondence Entered
Oct 15, 2020
Correspondence Received In Law Office
Oct 1, 2020
Teas Response To Office Action Received
Apr 1, 2020
Notification Of Non-Final Action E-Mailed
Apr 1, 2020
Non-Final Action E-Mailed
Apr 1, 2020
Non-Final Action Written
Mar 30, 2020
Teas/Email Correspondence Entered
Mar 30, 2020
Correspondence Received In Law Office
Mar 26, 2020
Teas Response To Office Action Received
Sep 27, 2019
Notification Of Non-Final Action E-Mailed
Sep 27, 2019
Non-Final Action E-Mailed
Sep 27, 2019
Non-Final Action Written
Sep 13, 2019
Teas/Email Correspondence Entered
Sep 13, 2019
Correspondence Received In Law Office
Sep 11, 2019
Assigned To Lie
Sep 5, 2019
Teas Response To Office Action Received
Mar 6, 2019
Notification Of Non-Final Action E-Mailed
Mar 6, 2019
Non-Final Action E-Mailed
Mar 6, 2019
Non-Final Action Written
Mar 6, 2019
Assigned To Examiner
Dec 28, 2018
New Application Office Supplied Data Entered In Tram
Dec 10, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24